You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 10,653,656


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,653,656 protect, and when does it expire?

Patent 10,653,656 protects ALTRENO and is included in one NDA.

This patent has eight patent family members in eight countries.

Summary for Patent: 10,653,656
Patent landscape, scope, and claims:
Title:Topical pharmaceutical compositions for treating skin conditions
Abstract: In one aspect, topical pharmaceutical compositions for treating a skin condition or disorder are provided. In some embodiments, the topical pharmaceutical composition is formulated as a lotion and comprises a therapeutically effective amount of an active agent; a viscosity increasing agent; a polymeric emulsifier; and an oil component. In some embodiments, the topical pharmaceutical composition comprises tretinoin.
Inventor(s): Bhatt; Varsha (San Francisco, CA), Pillai; Radhakrishnan (Santa Rosa, CA)
Assignee: Bausch Health Ireland Limited (Dublin, IE)
Application Number:16/108,942
Patent Claim Types:
see list of patent claims
Use; Composition; Device;

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 10,653,656

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Dow Pharm ALTRENO tretinoin LOTION;TOPICAL 209353-001 Aug 23, 2018 RX Yes Yes 10,653,656 ⤷  Subscribe Y TOPICAL TREATMENT OF ACNE VULGARIS IN PATIENTS 9 YEARS OF AGE AND OLDER ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 10,653,656

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 114730 ⤷  Subscribe
Brazil 112020020431 ⤷  Subscribe
Canada 3095937 ⤷  Subscribe
European Patent Office 3773641 ⤷  Subscribe
Spain 2974819 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.